M Monden Selected Research

M Monden Research Topics

Disease

44	Neoplasms (Cancer) 08/2009 - 01/2000
19	Hepatocellular Carcinoma (Hepatoma) 05/2009 - 03/2000
14	Colorectal Neoplasms (Colorectal Cancer) 03/2007 - 02/2000
14	Neoplasm Micrometastasis 11/2005 - 03/2000
14	Neoplasm Metastasis (Metastasis) 09/2004 - 06/2000
11	Carcinoma (Carcinomatosis) 10/2001 - 01/2000
9	Esophageal Neoplasms (Esophageal Cancer) 01/2008 - 01/2000
9	Carcinogenesis 10/2006 - 02/2000
9	Stomach Neoplasms (Stomach Cancer) 01/2004 - 02/2000
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2004 - 01/2000
6	Colonic Neoplasms (Colon Cancer) 03/2007 - 01/2000
5	Breast Neoplasms (Breast Cancer) 12/2001 - 04/2000
5	Lymphatic Metastasis 06/2001 - 01/2000
5	Blister (Bulla) 05/2001 - 06/2000
4	Pancreatic Neoplasms (Pancreatic Cancer) 09/2009 - 03/2000
4	Esophageal Squamous Cell Carcinoma 05/2002 - 01/2000
3	Hypoxia (Hypoxemia) 05/2001 - 06/2000
2	Bile Duct Neoplasms (Bile Duct Cancer) 10/2001 - 06/2000
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2001 - 03/2001
2	Reperfusion Injury 02/2001 - 06/2000
2	Ischemia 02/2001 - 01/2001
2	Cholangiocarcinoma 01/2001 - 03/2000
2	Melanoma (Melanoma, Malignant) 06/2000 - 05/2000
2	Adenocarcinoma 05/2000 - 03/2000
1	Wounds and Injuries (Trauma) 07/2010
1	Pancreatic Ductal Carcinoma 09/2009
1	Anastomotic Leak 01/2008
1	Adenomatous Polyps 10/2006
1	Microsatellite Instability 09/2006
1	Nausea 12/2005
1	Vomiting 12/2005
1	Thrombosis (Thrombus) 09/2005
1	Gastrinoma 12/2002
1	Insulinoma 12/2002

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 08/2009 - 02/2000
12	Messenger RNA (mRNA)IBA 12/2006 - 02/2000
7	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2005 - 03/2000
6	Carcinoembryonic AntigenIBA 07/2001 - 02/2000
5	Fluorouracil (Carac)FDA LinkGeneric 05/2009 - 03/2000
5	Interferon-alpha (Interferon Alfa)IBA 05/2009 - 07/2000
5	Cadherins (E-Cadherin)IBA 05/2001 - 02/2000
5	Cyclin D1IBA 01/2001 - 01/2000
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2006 - 06/2000
3	beta CateninIBA 05/2009 - 05/2000
3	EnzymesIBA 12/2002 - 04/2000
3	Epidermal Growth Factor (EGF)IBA 07/2001 - 01/2001
3	Biomarkers (Surrogate Marker)IBA 01/2001 - 02/2000
3	Mammaglobin BIBA 06/2000 - 03/2000
2	Gemcitabine FDA Link 09/2009 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 05/2009 - 03/2004
2	InterferonsIBA 05/2009 - 09/2005
2	Complementary DNA (cDNA)IBA 09/2004 - 08/2001
2	Therapeutic UsesIBA 10/2001 - 09/2001
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2001 - 04/2000
2	Genetic Markers (Genetic Marker)IBA 09/2001 - 05/2001
2	Keratins (Keratin)IBA 09/2001 - 06/2000
2	cdc25 PhosphatasesIBA 09/2001 - 06/2000
2	enhanced green fluorescent proteinIBA 07/2001 - 05/2000
2	Green Fluorescent ProteinsIBA 07/2001 - 05/2000
2	Cyclin-Dependent Kinase Inhibitor p57IBA 07/2001 - 01/2001
2	ErbB Receptors (EGF Receptor)IBA 07/2001 - 05/2001
2	Cytosine DeaminaseIBA 05/2001 - 01/2001
2	CytokinesIBA 05/2001 - 02/2001
2	Keratin-20 (Cytokeratin 20)IBA 05/2001 - 07/2000
2	CateninsIBA 04/2001 - 03/2001
2	Dihydrotachysterol (AT 10)IBA 02/2001 - 01/2000
2	ferric oxide (iron oxide)IBA 01/2001 - 08/2000
2	Cyclin B1IBA 12/2000 - 06/2000
2	Prostate-Specific Antigen (Semenogelase)IBA 06/2000 - 05/2000
2	Indicators and Reagents (Reagents)IBA 02/2000 - 02/2000
1	Bromodeoxyuridine (BrdU)IBA 05/2009
1	VimentinIBA 03/2007
1	PPAR deltaIBA 10/2006
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2006
1	Transforming Growth Factor-beta Type II ReceptorIBA 09/2006
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 12/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2005
1	Granisetron (Kytril)FDA LinkGeneric 12/2005
1	Interferon Receptors (Interferon Receptor)IBA 09/2005
1	Valosin Containing ProteinIBA 09/2004
1	NF-kappa B (NF-kB)IBA 09/2004
1	Calcibiotic Root Canal SealerIBA 09/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2002
1	MetallothioneinIBA 05/2002

Therapy/Procedure

15	Therapeutics 09/2009 - 01/2000
8	Drug Therapy (Chemotherapy) 09/2009 - 03/2000
6	Hepatectomy 10/2001 - 04/2000
4	Lymph Node Excision (Lymph Node Dissection) 11/2005 - 01/2001
4	Radiotherapy 05/2002 - 12/2000
3	Esophagectomy 01/2008 - 01/2000
2	Operative Surgical Procedures 07/2010 - 08/2003
2	Adjuvant Chemotherapy 09/2009 - 01/2001
2	Gastrectomy 01/2008 - 10/2001
2	Segmental Mastectomy (Lumpectomy) 12/2001 - 04/2000
1	Cholecystectomy 07/2010
1	Length of Stay 01/2008
1	Liver Transplantation 12/2006
1	Chemoprevention 10/2006
1	Sternotomy 08/2003